CoChat

A gonadotrophin‐releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis

Vercellini, Paolo, Crosignani, Pier Giorgio, Fadini, Ruben, Radici, Enrico, Belloni, Carlo, Sismondi, Piero · 1999 · BJOG: An International Journal of Obstetrics & Gynaecology
Cited by 147

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Objective To ascertain whether the frequency of pelvic pain recurrence is reduced and time to symptoms recurrence is prolonged in women with symptomatic endometriosis undergoing conservative surgery and post‐operative hormonal therapy compared with women treated with surgery only. Pregnancy rates and time to conception in women wanting children were also evaluated. Design A multicentre, prospective, randomised controlled study. Setting Nineteen Italian academic departments and teaching hospitals specialising in reparative and reconstructive surgery. Population A total of 269 women undergoing conservative surgery for mild to severe symptomatic endometriosis. Methods After surgery the women were assigned to treatment with subcutaneous goserelin depot injections for six months or to expectant management. Dysmenorrhoea, deep dyspareunia, nonmenstrual pain and general discomfort were graded according to a verbal rating scale from 0 (absent) to 3 (severe) and the scores summed to give a total symptoms score. Only patients with at least one preoperative moderate or severe symptom were enrolled. The women were evaluated regularly for two years. Main outcome measures Post‐operative pain recurrences (total symptoms scores ≥ 5), time to recurrence, pregnancy rates and time to conception in the two study groups. Results At oneand two‐year follow up visits, 14/107 (13.1%) and 19/81 (23.5%) patients had moderate or severe symptoms recurrence in the goserelin group compared with, respectively, 22/103 (21.4%) and 27/74 (36.5%) in the expectant management group (P= 0.143 at 1 year and 0.082 at 2 years). Time to symptoms recurrence was significantly longer in the goserelin group according to survival analysis (Wilcoxon test, P= 0.041). Among women wanting children, few conceptions occurred in both the goserelin (8/69, 11.6%) and the expectant management group (14/76, 18.4%). There was no significant difference at survival analysis (Wilcoxon test, P= 0.427). Conclusion Post‐operative treatment with goserelin significantly prolonged the pain‐free interval after conservative surgery for symptomatic endometriosis and did not influence reproductive prognosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-0528.1999.tb08366.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 147

Metadata

Authors
Vercellini, P., Crosignani, P. G., Fadini, R., Radici, E., Belloni, C., & Sismondi, P.
Venue
BJOG: An International Journal of Obstetrics & Gynaecology
Publisher
Wiley
Published
1999-07
Volume
106
Issue
7
Pages
672-677
ISSN
  • 0306-5456 (ISSN-L)
  • 1470-0328
  • 1471-0528
OpenAlex
W2028587418
Cited by
147
References
3
FWCI
3.10
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A gonadotrophin‐releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis. https://app.cochat.ai/papers/10.1111/j.1471-0528.1999.tb08366.x
The paper
Vercellini, P., Crosignani, P. G., Fadini, R., Radici, E., Belloni, C., & Sismondi, P. (1999). A gonadotrophin‐releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/j.1471-0528.1999.tb08366.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.